Calidi Biotherapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2021 | — | $0 | $0 |
| Mar 2021 | — | $25.0K | — |
| Apr 2021 | — | $15.0K | — |
| Jun 2021 | — | $-58.3K | $95.0K |
| Sep 2021 | — | $-19.0M | $1.2M |
| Dec 2021 | — | $-31.6M | $1.1M |
| Mar 2022 | — | $-37.6M | $597.5K |
| Jun 2022 | — | $-39.6M | $328.8K |
| Sep 2022 | — | $-43.9M | $300.0K |
| Dec 2022 | — | $-50.4M | $590.0K |
| Mar 2023 | — | $-55.1M | $1.1M |
| Jun 2023 | — | $-63.7M | $2.3M |
| Sep 2023 | $2.0M | $-1.1M | $10.4M |
| Dec 2023 | $2.1M | $-8.2M | $2.2M |
| Mar 2024 | $3.4M | $-14.6M | $1.2M |
| Jun 2024 | $1.9M | $-11.8M | $800.0K |
| Sep 2024 | $2.4M | $-9.8M | $1.9M |
| Dec 2024 | $600.0K | $1.5M | $9.6M |
| Mar 2025 | $600.0K | $6.9M | $10.8M |
| Jun 2025 | $600.0K | $1.8M | $5.4M |
| Sep 2025 | $600.0K | $6.9M | $10.6M |
| Dec 2025 | $600.0K | $3.8M | $5.8M |
| Mar 2026 | $600.0K | $4.9M | $6.9M |
| Jun 2026 | $600.0K | $3.1M | $4.3M |